Raymond James Financial’s Boston Scientific BSX Stock Holding History

Raymond James Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.1M	Sell	1,923,305 -1,105,792	-37%	-$60M	0.02%	663
2026 Q1	$190M	Sell	3,029,097 -503,955	-14%	-$40.3M	0.06%	289
2025 Q4	$337M	Buy	3,533,052 +375,845	+12%	+$36.8M	0.1%	162
2025 Q3	$308M	Buy	3,157,207 +779,938	+33%	+$80.8M	0.1%	185
2025 Q2	$255M	Buy	2,377,269 +199,932	+9%	+$20.2M	0.09%	210
2025 Q1	$220M	Buy	2,177,337 +41,422	+2%	+$4.17M	0.08%	224
2024 Q4	$191M	Buy	+2,135,915	New	+$188M	0.07%	249

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Raymond James Financial's BSX Position: Q2 2026 in Review

Raymond James Financial reduced its Boston Scientific (BSX) stake by 37% in Q2 2026, selling an estimated $60M and leaving 1,923,305 shares worth $82.1M. The position accounts for 0.02% of the portfolio, ranked #663.

Raymond James Financial first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $337M in Q4 2025. 1,486 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Raymond James Financial held 1,923,305 shares of Boston Scientific worth $82.1M as of Q2 2026.
Raymond James Financial sold 1,105,792 Boston Scientific shares in Q2 2026, an estimated $60M.
Boston Scientific made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #663 holding.
Raymond James Financial first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's Boston Scientific position peaked at $337M in Q4 2025.
1,486 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.